Company Filing History:
Years Active: 2025
Title: Innovations by Hermes Garbán in Cancer Treatment
Introduction
Hermes Garbán is an innovative inventor based in Los Angeles, CA. He has made significant contributions to the field of cancer treatment through his research and development of novel therapeutic approaches. His work focuses on the use of chimeric T cell receptors to enhance the immune response against tumor cells.
Latest Patents
Hermes Garbán holds a patent for "Chimeric T cell receptors, nucleic acids, and methods of making and using the same." This patent outlines compositions and methods for eradicating tumor cells using novel pharmaceutical compositions. The invention includes a CAR scaffold that may comprise a CD28 costimulatory signaling region and a CD3ζ activation domain. Additionally, the CAR scaffold can be codon-optimized for improved expression in mammalian cell lines, enhancing its function upon transfection into natural killer (NK) or other immune cells.
Career Highlights
Hermes Garbán has been associated with Nantbio, Inc., where he continues to push the boundaries of cancer research. His work has the potential to revolutionize the way tumors are treated, providing new hope for patients facing challenging diagnoses. With a focus on innovative solutions, Garbán is at the forefront of developing therapies that could significantly impact cancer treatment.
Collaborations
(Section skipped due to space constraints.)
Conclusion
Hermes Garbán's contributions to the field of cancer treatment through his innovative patent demonstrate his commitment to advancing medical science. His work at Nantbio, Inc. highlights the importance of research in developing effective therapies for cancer patients.